John Paul Rohmer

• +33 6 30 08 84 28
• jp.rohmer@priscus.eu

Sectorial expertise :

Geographic expertise :

Biography :

40 years’ experience in the bio-pharmaceutical and life sciences sector, in France, the United States and Europe. He held management positions at Eli Lilly, a US pharmaceutical company, in marketing, strategic planning and development. He then became CEO of Stallergènes, a French laboratory specialising in immunoallergology. He was involved in a number of major acquisitions and strategic investments. and strategic investments. He led two successful IPOs: Stallergènes in 1998 and Medesis Pharma in 2021.

Today, he combines his activities as a strategy consultant, independent director and operational manager. He has participated in the creation and financing of several companies in the biopharmaceutical sector, and has supported their their development. He has also acted on several occasions as a private investor in biopharmaceutical and related projects. In total, it has invested in more than 25 companies in the sector. For the past 5 years, he has been a Senior Advisor in the bio-health sector at Priscus Finance.

Education:
Universities of Sorbonne (DES in economics and econometrics)
Paris-Dauphine and CEPE (doctorate in management science)

Technical skills: Strategic advisory
Business plan
Team management